Menopause Insights: Trends in Hormone Replacement Therapy Usage Among Women
Understanding the Decline in Hormone Replacement Therapy Usage
According to a recent study published online in JAMA Health Forum, the use of menopausal hormone therapy (MHT) has dramatically decreased among postmenopausal women in the United States from 1999 to 2020.
Key Findings of the Study
- MHT prevalence dropped from 26.9% to 4.7% across all age groups.
- For women aged 52-65, MHT usage decreased significantly until 2002, with younger women (<52 years) seeing increased usage starting in 2005.
- Prevalence declined across racial and ethnic groups, including a drop from 13.8% to 2.6% for Hispanic women and 31.4% to 5.8% for non-Hispanic White women.
The researchers evaluated data from the National Health and Nutrition Examination Survey, analyzing responses from 13,048 postmenopausal women, which revealed critical insights into the evolving landscape of menopausal treatment.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.